Detalhe da pesquisa
1.
Treatment patterns and prognosis in patients with Bacillus Calmette-Guérin-exposed high-risk non-muscle invasive bladder cancer: a real-world data analysis.
World J Urol
; 42(1): 185, 2024 Mar 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-38512511
2.
Enfortumab vedotin following platinum-based chemotherapy and immune checkpoint inhibitors for advanced urothelial carcinoma: response, survival and safety analysis from a multicentre real-world Japanese cohort.
Jpn J Clin Oncol
; 54(3): 329-338, 2024 Mar 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-38061911
3.
Dissociated response among multiple metastatic lesions in the patients with metastatic renal cell carcinoma treated with immune checkpoint inhibitors.
Jpn J Clin Oncol
; 52(12): 1430-1435, 2022 Dec 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36093731
4.
Bacillus Calmette-Guérin-unresponsive non-muscle invasive bladder cancer outcomes in patients without radical cystectomy.
Int J Clin Oncol
; 26(11): 2104-2112, 2021 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-34313904
5.
Docetaxel-based chemotherapy combined with dexamethasone 1 mg daily oral administration for castration-resistant prostate cancer: Long-term outcomes.
Int J Urol
; 26(8): 797-803, 2019 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-31055879
6.
The efficacy and safety of docetaxel-based chemotherapy combined with dexamethasone 1 mg daily oral administration: JMTO Pca 10-01 phase II trial.
Jpn J Clin Oncol
; 47(3): 247-251, 2017 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28042138
7.
Risk factors of PSA progression and overall survival in patients with localized and locally advanced prostate cancer treated with primary androgen deprivation therapy.
BMC Cancer
; 15: 420, 2015 May 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-25990314
8.
Nadir PSA level and time to nadir PSA are prognostic factors in patients with metastatic prostate cancer.
BMC Urol
; 14: 33, 2014 Apr 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-24773608
9.
Improvement of the surgical curability of locally confined prostate cancer including non-organ-confined high-risk disease through retropubic radical prostatectomy with intentional wide resection.
World J Surg Oncol
; 10: 249, 2012 Nov 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-23158926
10.
Angiographic embolisation of a ruptured renal artery aneurysm in a primigravida during the first trimester.
J Obstet Gynaecol
; 37(2): 254-256, 2017 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-27868458
11.
Organ-Specific and Mixed Responses to Pembrolizumab in Patients with Unresectable or Metastatic Urothelial Carcinoma: A Multicenter Retrospective Study.
Cancers (Basel)
; 14(7)2022 Mar 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-35406508
12.
Risk-stratified survival rates and predictors of biochemical recurrence after radical prostatectomy in a Nara, Japan, cohort study.
Int J Clin Oncol
; 16(5): 553-9, 2011 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-21437569
13.
Site-specific Response to Nivolumab in Renal Cell Carcinoma.
Anticancer Res
; 41(3): 1539-1545, 2021 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-33788747
14.
External validation of a genitourinary cancer-specific prognostic scoring system to predict survival for patients with bone metastasis (modified B-FOM scoring model): Comparison with other scoring models in terms of accuracy.
J Bone Oncol
; 26: 100344, 2021 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-33384916
15.
Intravesical Bacillus Calmette-Guérin Treatment for T1 High-Grade Non-Muscle Invasive Bladder Cancer with Divergent Differentiation or Variant Morphologies.
Cancers (Basel)
; 13(11)2021 May 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-34073436
16.
Cancer death from non-muscle invasive bladder cancer: report of the Japanese Urological Association of data from the 1999-2001 registry in Japan.
Int J Urol
; 17(11): 905-12, 2010 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-20969637
17.
D2-40/podoplanin expression in cancer stroma by immunohistochemical staining is associated with poor prognosis in bladder cancer patients after radical cystectomy.
Urol Oncol
; 38(10): 797.e7-797.e13, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32576528
18.
Integrative assessment of clinicopathological parameters and the expression of PD-L1, PD-L2 and PD-1 in tumor cells of retroperitoneal sarcoma.
Oncol Lett
; 20(5): 190, 2020 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-32952659
19.
Bladder cancer develops 6 years earlier in current smokers: analysis of bladder cancer registry data collected by the cancer registration committee of the Japanese Urological Association.
Int J Urol
; 16(1): 64-9, 2009 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-19054170
20.
Clinical outcome of tumor recurrence for Ta, T1 non-muscle invasive bladder cancer from the data on registered bladder cancer patients in Japan: 1999-2001 report from the Japanese Urological Association.
Int J Urol
; 16(3): 279-86, 2009 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-19207609